During the past decade, Adult Brain Tumor Consortium conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Adult Brain Tumor Consortium" are "Adult Giant Cell Glioblastoma" (4 trials), "Adult Gliosarcoma" (4 trials), "Adult Glioblastoma" (3 trials), "Adult Anaplastic Astrocytoma" (2 trials) and "Adult Anaplastic Oligodendroglioma" (2 trials). Many other conditions were trialed in "Adult Brain Tumor Consortium" in a lesser frequency.

Most popular intervention types in "Adult Brain Tumor Consortium" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "pharmacological study" (2 trials), "radiation therapy" (2 trials), "temozolomide" (2 trials), "Cediranib Maleate" (1 trials) and "Cilengitide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Adult Brain Tumor Consortium" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Adult Brain Tumor Consortium". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Adult Brain Tumor Consortium, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Adult Brain Tumor Consortium, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".